DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Manali Petrochemicals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 37 min ago·9 Sept 2026, 9:28 am

Manali Petrochemicals LT

Manali Petrochemicals has informed stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This compliance document confirms that the company's shares are being held in electronic form by a registered Depository Participant, adhering to the regulatory framework for dematerialized securities.

This regulatory filing is a standard procedural update. For investors, it confirms that the company's shareholding structure is fully compliant with market regulations, ensuring that shares can be seamlessly dematerialized and transferred electronically without any regulatory hurdles.

Investors should monitor the company's upcoming quarterly results. Any significant changes in production volumes or raw material costs will be more relevant to the stock's performance than this routine regulatory compliance update.